Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC).
about
Adoptive immunotherapy of cytokine-induced killer cell therapy in the treatment of non-small cell lung cancerProteomic-Based Approaches for the Study of Cytokines in Lung CancerClinical application of adoptive T cell therapy in solid tumorsConvergence of Innate and Adaptive Immunity during Human AgingAdoptive immunotherapy with interleukin-2 & induced killer cells in non-small cell lung cancer: A systematic review & meta-analysisDendritic cell-activated cytokine-induced killer cell-mediated immunotherapy is safe and effective for cancer patients >65�years oldMultivariate statistical data analysis as a tool to analyze ex vivo expansion dynamics of cytokine-induced killer cells.Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients.Dendritic cells decreased the concomitant expanded Tregs and Tregs related IL-35 in cytokine-induced killer cells and increased their cytotoxicity against leukemia cells.Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer.Clinical effects of autologous dendritic cells combined with cytokine-induced killer cells followed by chemotherapy in treating patients with advanced colorectal cancer: a prospective study.Cytokine-induced killer cell therapy-associated idiopathic thrombocytopenic purpura: rare but noteworthy.Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy.Immunotherapeutic Intervention against Sarcomas.Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures.Human leukocyte antigen-haploidentical donor-derived cytokine-induced killer cells are safe and prolong the survival of patients with advanced non-small cell lung cancer.Combined therapy with cytokine-induced killer cells and oncolytic adenovirus expressing IL-12 induce enhanced antitumor activity in liver tumor modelCytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC).Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients.Evaluation of tumor response to cytokine-induced killer cells therapy in malignant solid tumors.The clinical effects of dendritic cell vaccines combined with cytokine-induced killer cells intraperitoneal injected on patients with malignant ascitesEffects of MICA expression on the prognosis of advanced non-small cell lung cancer and the efficacy of CIK therapyEffectiveness of immune therapy combined with chemotherapy on the immune function and recurrence rate of cervical cancer.Current advances in T-cell-based cancer immunotherapyRevving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies.Increased survival time of a patient with metastatic malignant melanoma following immunotherapy: A case report and literature review.Efficacy of adjuvant chemotherapy combined with immunotherapy with cytokine-induced killer cells for gastric cancer after d2 gastrectomy.An effective cytokine adjuvant vaccine induces autologous T-cell response against colon cancer in an animal model.Chemotherapy plus dendritic cells co-cultured with cytokine-induced killer cells versus chemotherapy alone to treat advanced non-small-cell lung cancer: A meta-analysis.A Positive Role of Cytokine-Induced Killer Cell Therapy on Gastric Cancer Therapy in a Chinese Population: A Systematic Meta-Analysis.The combination of dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors.Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer.Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safetyEfficacy study of CyberKnife stereotactic radiosurgery combined with CIK cell immunotherapy for advanced refractory lung cancer.Anti-Programmed Cell Death (PD)-1 Immunotherapy for Malignant Tumor: A Systematic Review and Meta-Analysis.Cytokine-induced killer cells promote antitumor immunityCytokine-induced killer cell therapy for advanced pancreatic adenocarcinoma: A case report and review of the literatureA randomized controlled trial on patients with or without adjuvant autologous cytokine-induced killer cells after curative resection for hepatocellular carcinoma.Implication of combined PD-L1/PD-1 blockade with cytokine-induced killer cells as a synergistic immunotherapy for gastrointestinal cancer.Efficacy of RetroNectin-activated cytokine-induced killer cell therapy in the treatment of advanced hepatocelluar carcinoma.
P2860
Q21089654-0AB7E6F8-763D-4039-AAF8-3FC578B48529Q26738539-EB546573-624B-4B33-A766-D72DE38AE962Q27011283-B5A4DBCD-4612-4EE5-AAC2-CE8393B859B5Q28069527-D95D7FD0-0310-4D81-BEC9-30AAC2C863D8Q28072200-A65F1C42-F519-4812-BE80-1C00F1ED2CF0Q28468347-D2AEAE10-A2C1-408E-B4C3-9F664E0AD515Q30664844-D682E989-18D6-4BF1-A2A6-12B579204E1CQ31157425-09AFD740-4CF5-4D8A-B437-BC7202045A7AQ31157715-036B6C9F-C051-48DF-B95A-9AF8719F293BQ33415850-95E94B9C-92E3-46B4-A8F6-B91352435D49Q33427019-BE5BD1E8-725C-4F9A-8BE3-7979AEA68097Q33434310-00A40B96-A4D6-4103-839B-B45488ABBE0CQ33875615-1D434B33-D7DB-4AF3-997D-FAADB0562EBDQ34196481-16BF16B8-49CE-472D-9ACB-B3532D593E71Q34419059-51B4D999-C215-41E8-A35A-42796B82C3C1Q34427336-2E8EC78F-8977-4EBB-BD38-A7D036E29A8DQ34427459-683CAA20-4923-477D-B461-8FEA9E2A301DQ34446934-0E6F5C09-C2C5-48E6-81FE-50A4C47C1D0DQ34450648-679B2B16-1AB0-4916-B9A3-18948324EDBCQ34635795-B6ACC65B-576F-4F9F-BF54-96042667CD9DQ34769958-FC848142-4498-4C79-9CA5-8F8BCC0960D8Q34918975-018A90D0-E46A-487B-9E05-039BAE2927CBQ35048698-0C5A83AF-EA7E-407B-AC10-66A3307C82E9Q35215158-89DC552B-2380-4B42-A9B7-2E9B7AB36134Q35600095-D6B3AD08-49A2-408E-8E24-EC0809E83401Q35870544-C4C995CE-51EB-4EC8-ABEB-C1254CC0DFB0Q35870886-DC49E19F-80EA-438C-A1A8-5D544B20E5D0Q36145145-E9293FE9-BA41-4F59-A65E-0C194906C37FQ36198098-914184D4-A3E5-471B-97DF-7DDF92243D90Q36263711-65F87594-208A-4968-BA6D-0C86343F9396Q36270334-F5424222-C8C2-4F66-894E-E75020117440Q36422925-1391A0E4-1F5D-4E4D-BB8A-4B61FF767FC4Q36444510-7D3A72D9-B5D2-432F-8357-06C3B80BED10Q36603716-24789F2E-9151-46C1-B6B3-5BEDB048DAABQ36707137-7FB5FB7F-1195-42EC-B133-5BC0EF286875Q36741617-3AD5A19B-D028-4A79-A5D0-7DAF81DF218BQ36774574-B6DC75C1-D9F4-4226-969F-E0D152FA78FFQ36821044-309606E7-62B1-4A81-AAA1-34E0DDF6BB36Q36962962-23B40133-FD01-491E-BF2F-FDE8C566BE5AQ37002698-B6160D88-EFB0-4EDF-A034-0DA1248464AB
P2860
Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC).
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clinical trials on CIK cells: ...... registry on CIK cells (IRCC).
@ast
Clinical trials on CIK cells: ...... registry on CIK cells (IRCC).
@en
Clinical trials on CIK cells: first report of the international registry on CIK cells
@nl
type
label
Clinical trials on CIK cells: ...... registry on CIK cells (IRCC).
@ast
Clinical trials on CIK cells: ...... registry on CIK cells (IRCC).
@en
Clinical trials on CIK cells: first report of the international registry on CIK cells
@nl
prefLabel
Clinical trials on CIK cells: ...... registry on CIK cells (IRCC).
@ast
Clinical trials on CIK cells: ...... registry on CIK cells (IRCC).
@en
Clinical trials on CIK cells: first report of the international registry on CIK cells
@nl
P2093
P2860
P1476
Clinical trials on CIK cells: ...... registry on CIK cells (IRCC).
@en
P2093
C Hontscha
I G H Schmidt-Wolf
P2860
P2888
P304
P356
10.1007/S00432-010-0887-7
P577
2010-04-21T00:00:00Z